Does location of an non-spinal osseous metastasis affect your SBRT dosing?

Just a few thoughts: Location is an important consideration for SBRT dosing because normal tissue tolerances vary by organ/location. Three complications that I worry about are the risk of bone fracture, neuropathy and myositis when treating non spinal osseous mets with SBRT, especially in the settin...

Proximity to visceral organs and joints and whether the bone is weight-bearing are factors that I will consider. I favor multisession SBRT for higher risk bone metastases.